PayerPrice
Data Platform
Who We Serve
Use Cases
More
Check Local Rates

HCPCS G0482 Fee Schedule

Last Verified: September 2026

Healthcare providers use this code to document and receive reimbursement for visits that address moderate-level medical decision-making, often including multiple diagnoses or prescription management.

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed
Key FactDetail
Service Type

Procedures / Professional Services

Other Services

Complexity LevelLow
Medicaid Fee ScheduleView Medicaid rates for G0482

National average reimbursement for HCPCS G0482 by major payers:

bcbs

$141.30

uhc

$111.30

aetna

$181.79

cigna

$148.15

Compare published rates across providers.

Choose a payer to see a sample of rates for HCPCS G0482.

HCPCS G0482
5 of 25 sample ratesHigher to lower in this preview
  1. William Westra

    H Lee Moffitt Cancer Ctr & Res Inst Life Time Cancer Scrn Ctr Inc

    MDAnatomic Pathology & Clinical Pathology PhysicianNPI 1114953346Tax ID 59-3238640

    $119.23Published rate
  2. Kathrin Dvir

    H Lee Moffitt Cancer Ctr & Res Inst Life Time Cancer Scrn Ctr Inc

    FLHematology & Oncology PhysicianNPI 1417441163Tax ID 59-3238640

    $119.23Published rate
  3. Ling Zhang

    H Lee Moffitt Cancer Ctr & Res Inst Life Time Cancer Scrn Ctr Inc

    TXPhysical Medicine & Rehabilitation PhysicianNPI 1134328214Tax ID 59-3238640

    $119.23Published rate
  4. Matthew Wallace

    H Lee Moffitt Cancer Ctr & Res Inst Life Time Cancer Scrn Ctr Inc

    MIMedical Physician AssistantNPI 1427321041Tax ID 59-3238640

    $101.36Published rate
  5. Ana Rica Nguyen

    H Lee Moffitt Cancer Ctr & Res Inst Life Time Cancer Scrn Ctr Inc

    FLCertified Registered Nurse AnesthetistNPI 1346762069Tax ID 59-3238640

    $101.36Published rate

National sample. Rates vary by location, specialty, and contract.

Get a free rate benchmark for your specialty.

Choose your state and specialty to build a report from payer-published rates.

Use market rates to prepare your payer proposal.

Rate Benchmarking

Compare your rates with similar providers.

Select a published rate, define comparable providers, and see where that rate falls in your market.

See a sample rate comparison

Payer Contract Negotiation

Draft a fee schedule renegotiation letter.

Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.

See a sample payer proposal

HCPCS G0482 vs. Other Other Services Codes

The HCPCS G0482 code is part of the Procedures / Professional Services services used for Other Services. It represents a moderate-complexity encounter and is one of several codes that vary based on time spent, level of medical decision-making, and documentation requirements.

The HCPCS G0482 code involves more provider time and moderate medical decision-making, unlike lower-level codes that require less time and simpler assessments. It typically includes multiple diagnoses, medication management, or test interpretation, leading to higher reimbursement and more detailed documentation requirements.

CodeComplexityDescription
G0481-HCPCSLowDrug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed
G0482-HCPCSLowDrug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed
G0483-HCPCSLowDrug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed

What is a fee schedule?

A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS G0482. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.

Understanding the G0482 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.

Factors that affect fee schedules


Medicare & Medicaid Rates

Government-set reimbursement amounts


Private Insurance Rates

Negotiated rates between providers and insurance companies


Geographic Location

Costs may be higher in urban areas.


Provider Type

Hospital providers may have different rates than private practice.

FREE SAMPLE MARKET COMPARISON

Let's review your payer contracts side-by-side with the market.

Bring your top codes (like HCPCS G0482) and we'll show you how you compare in 15 minutes or less.